ONWARD Medical secures €40.6M to accelerate Breakthrough Therapies for Spinal Cord Injuries
Eindhoven-based neurotechnology company ONWARD Medical has raised €40.6 million through an accelerated private placement, strengthening its mission to develop therapies that restore movement and independence for people with spinal cord injuries and related disorders.

The best Articles in our Network